You are here: Home » Companies » Results
Business Standard

Biocon consolidated net profit rises 18% to Rs 220 crore in Q3

Biosimilars vertical clocked revenue of Rs 981.4 crore as compared to Rs 768.9 crore in the same quarter last fiscal

Topics
Biocon | Q3 results

Press Trust of India  |  New Delhi 

SAT stays Biocon insider trading order

Biotechnology major Ltd on Thursday reported a 17.68 per cent increase in consolidated net profit at Rs 219.6 crore for the third quarter ended December 31, 2021.

The company had posted a consolidated net profit of Rs 186.6 crore in the same quarter of the previous fiscal, Ltd said in a regulatory filing.

Consolidated total income in the third quarter this fiscal stood at Rs 2,222.5 crore as compared to Rs 1,885.3 crore in the corresponding period a year ago.

Biosimilars vertical clocked revenue of Rs 981.4 crore as compared to Rs 768.9 crore in the same quarter last fiscal, while the generics segment had a revenue of Rs 607.4 crore as against Rs 567.1 crore earlier, the filing said.

The company further said its research services registered a revenue of Rs 641.4 crore in the third quarter as against Rs 584.5 crore in the same period last fiscal.

Total expenses during the period under review stood at Rs 1,906.4 crore as against Rs 1,648.7 crore in the year-ago quarter.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, January 20 2022. 22:53 IST
RECOMMENDED FOR YOU
.